ABBV Revenue
Quarterly revenue, the top-line sales a company books before any costs are subtracted.
Revenue
Latest: $16.99B (2026Q2)
| Period | Value |
|---|---|
| 2020Q3 | $12.90B |
| 2020Q4 | $13.86B |
| 2021Q1 | $13.01B |
| 2021Q2 | $13.96B |
| 2021Q3 | $14.34B |
| 2021Q4 | $14.89B |
| 2022Q1 | $13.54B |
| 2022Q2 | $14.58B |
| 2022Q3 | $14.81B |
| 2022Q4 | $15.12B |
| 2023Q1 | $12.22B |
| 2023Q2 | $13.87B |
| 2023Q3 | $13.93B |
| 2023Q4 | $14.30B |
| 2024Q1 | $12.31B |
| 2024Q2 | $14.46B |
| 2024Q3 | $14.46B |
| 2024Q4 | $15.10B |
| 2025Q1 | $13.34B |
| 2025Q2 | $15.42B |
| 2025Q3 | $15.78B |
| 2025Q4 | $16.62B |
| 2026Q1 | $15.00B |
| 2026Q2 | $16.99B |
Other ABBV Charts
More quarter-by-quarter fundamentals for AbbVie Inc.
1 / 10
EPS
Free Cash Flow
Gross Margin
FCF Margin
P/E Ratio
Cumulative FCF
Shares Outstanding
Total Assets
Total Debt
Rule of 40
Healthcare Comparison
1 / 3
Latest Revenue: $16.99B (2026Q2); +10.2% YoY; +10.9% CAGR since 2013Q1 (13.25y).
Across the 54 quarters from 2013Q1 to 2026Q2, Revenue ranged from $4.33B in 2013Q1 to $16.99B in 2026Q2.
Chart and table show the latest 24 of 54 quarters.